These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
558 related articles for article (PubMed ID: 12642709)
1. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG. Nakamoto Y; Osman M; Wahl RL Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709 [TBL] [Abstract][Full Text] [Related]
2. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography. Ak I; Sivrikoz MC; Entok E; Vardareli E Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657 [TBL] [Abstract][Full Text] [Related]
3. Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer. Gayed I; Vu T; Johnson M; Macapinlac H; Podoloff D Mol Imaging Biol; 2003; 5(1):26-31. PubMed ID: 14499159 [TBL] [Abstract][Full Text] [Related]
4. 18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract. Kim MR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY Oral Oncol; 2008 Feb; 44(2):148-52. PubMed ID: 17350879 [TBL] [Abstract][Full Text] [Related]
5. Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer. Yang SN; Liang JA; Lin FJ; Kao CH; Lin CC; Lee CC J Cancer Res Clin Oncol; 2002 Jun; 128(6):325-8. PubMed ID: 12073051 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases. Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313 [TBL] [Abstract][Full Text] [Related]
7. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027 [TBL] [Abstract][Full Text] [Related]
8. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases. Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175 [TBL] [Abstract][Full Text] [Related]
9. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262 [TBL] [Abstract][Full Text] [Related]
10. Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients. Ozülker T; Küçüköz Uzun A; Ozülker F; Ozpaçac T Nucl Med Commun; 2010 Jun; 31(6):597-603. PubMed ID: 20224457 [TBL] [Abstract][Full Text] [Related]
11. CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination. Nakamoto Y; Cohade C; Tatsumi M; Hammoud D; Wahl RL Radiology; 2005 Nov; 237(2):627-34. PubMed ID: 16244271 [TBL] [Abstract][Full Text] [Related]
12. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. Daldrup-Link HE; Franzius C; Link TM; Laukamp D; Sciuk J; Jürgens H; Schober O; Rummeny EJ AJR Am J Roentgenol; 2001 Jul; 177(1):229-36. PubMed ID: 11418435 [TBL] [Abstract][Full Text] [Related]
13. Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard ¹⁸F-FDG-PET/CT. Homann G; Mustafa DF; Ditt H; Spengler W; Kopp HG; Nikolaou K; Horger M Acad Radiol; 2015 Apr; 22(4):505-12. PubMed ID: 25586709 [TBL] [Abstract][Full Text] [Related]
15. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287 [TBL] [Abstract][Full Text] [Related]
16. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer. Lee JW; Lee SM; Lee HS; Kim YH; Bae WK Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551 [TBL] [Abstract][Full Text] [Related]
17. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors. Al-Bulushi NK; Abouzied ME Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992 [TBL] [Abstract][Full Text] [Related]
18. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315 [TBL] [Abstract][Full Text] [Related]
19. Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas. Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K Anticancer Res; 2005; 25(6C):4439-44. PubMed ID: 16334123 [TBL] [Abstract][Full Text] [Related]
20. Detection of bone metastases in thyroid cancer patients: bone scintigraphy or 18F-FDG PET? Phan HT; Jager PL; Plukker JT; Wolffenbuttel BH; Dierckx RA; Links TP Nucl Med Commun; 2007 Aug; 28(8):597-602. PubMed ID: 17625381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]